Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Journal of Allergy and Clinical Immunology, 2021Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis
Gülen T., Teufelberger A., Ekoff M. et al.
Scientific Reports, 2021Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
Patel R., Lam C., Svedlund S. et al.
Olink Target 96
Journal of Cardiac Failure, 2021Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF
Faxen U., Venkateshvaran A., Shah S. et al.
Nature Medicine, 2021A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
Zhou S., Butler-Laporte G., Nakanishi T. et al.
Acta Neurologica Scandinavica, 2021Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment
Zhukovsky C., Herman S., Wiberg A. et al.
Inflammatory Bowel Diseases, 2021Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
Verstockt S., Verstockt B., Machiels K. et al.
Diabetes, 2021Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes
Herder C., Maalmi H., Strassburger K. et al.
Cancers, 2021A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
Stroes C., Schokker S., Molenaar R. et al.
Scientific Reports, 2021The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
Wu P., Lin Y., Chiu Y. et al.
BioEssays, 2021Evaluation of 92 cardiovascular proteins in dried blood spots collected under field‐conditions
Broberg K., Svensson J., Grahn K. et al.
The Journal of Applied Laboratory Medicine, 2021Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury—A Pilot Study
Chen M., Ren A., Prassas I. et al.
Biomarkers in Medicine, 2021Associations of Serially Measured Pcsk9, Ldlr and Mpo with Clinical Outcomes in Heart Failure
Bouwens E., Schuurman A., Akkerhuis K. et al.
Computer Methods and Programs in Biomedicine, 2021Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling
Yaşar ?., Çolak C., Yoloğlu S.
Frontiers in Bioengineering and Biotechnology, 2021A LCMS Metabolomic Workflow to Investigate Metabolic Patterns in Human Intestinal Cells Exposed to Hydrolyzed Crab Waste Materials
Ó Fearghail F., Behan P., Engström N. et al.
Cardiovascular Ultrasound, 2021Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation
Jenner J., Ilami A., Petrini J. et al.
Cancer Research, 2021Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer
Dagnino S., Bodinier B., Guida F. et al.
Scientific Reports, 2021Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer
Jackson S., Van De Wyngard V., Pfeiffer R. et al.
Clinical Cancer Research, 2021A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Monjazeb A., Giobbie-Hurder A., Lako A. et al.
Nature Medicine, 2021Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Rozeman E., Hoefsmit E., Reijers I. et al.
Journal of Inherited Metabolic Disease, 2021Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures
Abdennadher M., Inati S., Soldatos A. et al.
4265 publications
Items per page
3701-3720 of 4265 publications